147 related articles for article (PubMed ID: 6214446)
1. In vitro mode of action, pharmacokinetics, and organ specificity of poly (maleic acid-styrene)-conjugated neocarzinostatin, SMANCS.
Takeshita J; Maeda H; Kanamaru R
Gan; 1982 Apr; 73(2):278-84. PubMed ID: 6214446
[TBL] [Abstract][Full Text] [Related]
2. [Tumor growth inhibitory effects of SMANCS, a poly (styrene-maleic acid) conjugated derivative of neocarzinostatin, on various tissue culture cells].
Suzuki F; Okuno Y; Maeda Y; Maeda H
Gan To Kagaku Ryoho; 1987 Dec; 14(12):3305-12. PubMed ID: 2961306
[TBL] [Abstract][Full Text] [Related]
3. Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH.
Oda T; Sato F; Maeda H
J Natl Cancer Inst; 1987 Dec; 79(6):1205-11. PubMed ID: 2961908
[TBL] [Abstract][Full Text] [Related]
4. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of SMANCS on rat mammary tumor induced by 7,12-dimethylbenz[a]anthracene.
Kimoto A; Konno T; Kawaguchi T; Miyauchi Y; Maeda H
Cancer Res; 1992 Feb; 52(4):1013-7. PubMed ID: 1531320
[TBL] [Abstract][Full Text] [Related]
6. Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer.
Oda T; Maeda H
Cancer Res; 1987 Jun; 47(12):3206-11. PubMed ID: 2953411
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of smancs in comparison with other anticancer agents against various cells in culture.
Oda T; Sato F; Yamamoto H; Akagi M; Maeda H
Anticancer Res; 1989; 9(2):261-5. PubMed ID: 2526613
[TBL] [Abstract][Full Text] [Related]
8. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.
Matsumura Y; Maeda H
Cancer Res; 1986 Dec; 46(12 Pt 1):6387-92. PubMed ID: 2946403
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
Suzuki F; Pollard RB; Maeda H
Cancer Immunol Immunother; 1989; 30(2):97-104. PubMed ID: 2480846
[TBL] [Abstract][Full Text] [Related]
10. Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma.
Abe S; Otsuki M
Curr Med Chem Anticancer Agents; 2002 Nov; 2(6):715-26. PubMed ID: 12678722
[TBL] [Abstract][Full Text] [Related]
11. [Stability of high molecular weight anticancer agent SMANCS and its transfer from oil-phase to water-phase. Comparative study with neocarzinostatin].
Hirayama S; Sato F; Oda T; Maeda H
Jpn J Antibiot; 1986 Mar; 39(3):815-22. PubMed ID: 3016359
[TBL] [Abstract][Full Text] [Related]
12. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy.
Maeda H
Adv Drug Deliv Rev; 2001 Mar; 46(1-3):169-85. PubMed ID: 11259839
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cytotoxic effects of the high- and low-molecular-weight anticancer agents on multidrug-resistant Chinese hamster ovary cells in vitro.
Miyamoto Y; Oda T; Maeda H
Cancer Res; 1990 Mar; 50(5):1571-5. PubMed ID: 2137371
[TBL] [Abstract][Full Text] [Related]
14. Differential neutralizing effect of tiopronin on the toxicity of neocarzinostatin and SMANCS: a new rescue cancer chemotherapy.
Oda T; Yamamoto H; Miki T; Maeda H
Jpn J Cancer Res; 1989 Apr; 80(4):394-9. PubMed ID: 2526108
[TBL] [Abstract][Full Text] [Related]
15. Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.
Ohtsuka N; Konno T; Miyauchi Y; Maeda H
Cancer; 1987 May; 59(9):1560-5. PubMed ID: 3030530
[TBL] [Abstract][Full Text] [Related]
16. Interferon induction by SMANCS: a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Munakata T; Maeda H
Anticancer Res; 1988; 8(1):97-103. PubMed ID: 2451896
[TBL] [Abstract][Full Text] [Related]
17. Enhanced intestinal absorption of a hydrophobic polymer-conjugated protein drug, smancs, in an oily formulation.
Oka K; Miyamoto Y; Matsumura Y; Tanaka S; Oda T; Suzuki F; Maeda H
Pharm Res; 1990 Aug; 7(8):852-5. PubMed ID: 2146602
[TBL] [Abstract][Full Text] [Related]
18. [General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics].
Matsumura Y; Oda T; Maeda H
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):821-9. PubMed ID: 2952066
[TBL] [Abstract][Full Text] [Related]
19. [Principle and therapeutic effect of lipophilic anticancer agent [SMANCS/lipiodol]: selective targeting with oily contrast medium].
Maeda H
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3323-31. PubMed ID: 2552930
[TBL] [Abstract][Full Text] [Related]
20. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
Hasegawa I; Hirashima N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
